Catherine L. Cioffi

2.0k citations

27 papers · 1.7k indexed · 1 hit paper · h-index 15

Molecular Biology top 10%
Hematology top 2%
Genetics top 5%
Pulmonary and Respiratory Medicine top 10%
Rheumatology top 5%

Co-authors: Sayuri Ohno-Jones Nicholas Lydon Norman M. Law Elisabeth Buchdunger David R. Stover Brian Druker Esam E. El‐Fakahany Brett P. Monia
Topics: Receptor Mechanisms and Signaling (13 papers)Protein Kinase Regulation and GTPase Signaling (8 papers)Neuroscience and Neuropharmacology Research (7 papers)
Cited by: Hematology Gastroenterology Genetics
Journals: Biochemical and Biophysical Research Communications Methods in enzymology on CD-ROM/Methods in enzymology Journal of Neurochemistry
Partner nations: United States Switzerland China

In The Last Decade

Catherine L. Cioffi

26 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors

2000 1.0k citations Catherine L. Cioffi et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers

Countries citing papers authored by Catherine L. Cioffi

Since Specialization

Citations

This map shows the geographic impact of Catherine L. Cioffi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine L. Cioffi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine L. Cioffi more than expected).

Fields of papers citing papers by Catherine L. Cioffi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine L. Cioffi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine L. Cioffi. The network helps show where Catherine L. Cioffi may publish in the future.

Co-authorship network of co-authors of Catherine L. Cioffi

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine L. Cioffi. A scholar is included among the top collaborators of Catherine L. Cioffi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine L. Cioffi. Catherine L. Cioffi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differential regulation of HIF-1α prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells 2003 ·Biochemical and Biophysical Research Communications ·Catherine L. Cioffi,Xiaoqin Liu,Penelope A. Kosinski,Michelle Garay,Benjamin R. Bowen	148
2	Inhibition of C-Jun N-Terminal Kinase 1, but Not c-Jun N-Terminal Kinase 2, Suppresses Apoptosis Induced by Ischemia/Reoxygenation in Rat Cardiac Myocytes 2001 ·Molecular Pharmacology ·David Hreniuk,(unknown),William A. Gaarde,Brett P. Monia,Robert A. McKay,Catherine L. Cioffi	107
3	Inhibition of C-Jun N-Terminal Kinase 1, but Not c-Jun N-Terminal Kinase 2, Suppresses Apoptosis Induced by Ischemia/Reoxygenation in Rat Cardiac Myocytes 2001 ·Molecular Pharmacology ·David Hreniuk,(unknown),William A. Gaarde,Brett P. Monia,Robert A. McKay,Catherine L. Cioffi	2
4	[25] Evaluation of biological role of c-Jun N-terminal kinase using an antisense approach 2000 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Catherine L. Cioffi,Brett P. Monia	10
5	Inhibition of hypoxia/reoxygenation-induced apoptosis by an antisense oligonucleotide targeted to JNK1 in human kidney cells 2000 ·Biochemical Pharmacology ·Michelle Garay,William A. Gaarde,Brett P. Monia,(unknown),Catherine L. Cioffi	34
6	Exposure of Human Vascular Smooth Muscle Cells to Raf-1 Antisense Oligodeoxynucleotides: Cellular Responses and Pharmacodynamic Implications 1998 ·Molecular Pharmacology ·Christoph Schumacher,Catherine L. Cioffi,H. Sharif,(unknown),Brett P. Monia,Lawrence P. Wennogle	9
7	Identification of a Novel Stress Activated Kinase in Kidney and Heart 1998 ·Biochemical and Biophysical Research Communications ·(unknown),Catherine L. Cioffi,Tinggui Yin,(unknown),Randy L. Webb,James Whelan	10
8	Molecular and Cellular Characterization of Baboon C-Raf as a Target for Antiproliferative Effects of Antisense Oligonucleotides 1997 ·Antisense and Nucleic Acid Drug Development ·Sreekala Mandiyan,Christoph Schumacher,Catherine L. Cioffi,H. Sharif,Anton Yuryev,Rodney W. Lappe,Brett P. Monia,Stephen R. Hanson,Stephen P. Goff,Lawrence P. Wennogle	10
9	In Vitroandin VivoEvaluation of an Endothelin Inhibitor Reveals Novel K+Channel Opening Activity 1996 ·Biochemical and Biophysical Research Communications ·Randy L. Webb,Shiling Hu,Matthew A. Sills,(unknown),Catherine L. Cioffi,(unknown),Rodney W. Lappe,Dean F. Rigel	0
10	The unusual binding properties of the endothelin receptor antagonist CGS 27830 distinguishes receptor/agonist interactions. 1996 ·PubMed ·(unknown),Catherine L. Cioffi,(unknown),Robert Neale,(unknown),Dominick DelGrande,(unknown),Matthew A. Sills,Kenneth E. Lipson	4
11	Stabilization of C5a receptor–G‐protein interactions through ligand binding 1994 ·Journal of Cellular Biochemistry ·Lawrence P. Wennogle,(unknown),(unknown),Albert Braunwalder,(unknown),Richard S. Kramer,Catherine L. Cioffi,Shou‐Ih Hu	9
12	Short-Term Regulation of Endothelin Receptor-Mediated Phosphoinositide Hydrolysis and Arachidonic Acid Release in A7r5 Smooth-Muscle Cells 1993 ·Journal of Cardiovascular Pharmacology ·Catherine L. Cioffi,Michelle Garay	3
13	Characterization of rat lung endothelin receptor subtypes which are coupled to phosphoinositide hydrolysis. 1992 ·Journal of Pharmacology and Experimental Therapeutics ·Catherine L. Cioffi,Robert Neale,Ronald H. Jackson,Matthew A. Sills	19
14	Reduction of Muscarinic Receptor Density and of Guanine Nucleotide‐Stimulated Phosphoinositide Hydrolysis in Human SH‐SY5Y Neuroblastoma Cells Following Long‐Term Treatment with 12‐O‐Tetradecanoylphorbol 13‐Acetate or Mezerein 1990 ·Journal of Neurochemistry ·Catherine L. Cioffi,Stephen K. Fisher	27
15	Molecular Mechanisms of Regulation of Neuronal Muscarinic Receptor Sensitivity 1990 ·PubMed ·Esam E. El‐Fakahany,Catherine L. Cioffi	25
16	Differential sensitivity of phosphoinositide and cyclic gmp responses to short-term regulation by a muscarinic agonist in mouse neuroblastoma cells 1989 ·Biochemical Pharmacology ·Catherine L. Cioffi,Esam E. El‐Fakahany	23
17	Lack of alterations in muscarinic receptor subtypes and phosphoinositide hydrolysis upon acute DFP treatment 1988 ·European Journal of Pharmacology ·Catherine L. Cioffi,Esam E. El‐Fakahany	9
18	Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine. 1988 ·Journal of Pharmacology and Experimental Therapeutics ·Esam E. El‐Fakahany,(unknown),(unknown),(unknown),Catherine L. Cioffi,Elliott Richelson,Michael McKinney	19
19	Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites. 1986 ·Journal of Pharmacology and Experimental Therapeutics ·Catherine L. Cioffi,Esam E. El‐Fakahany	42
20	Decreased binding of the muscarinic antagonist [3H]N-methylscopolamine in mouse brain following acute treatment with an organophosphate 1986 ·European Journal of Pharmacology ·Catherine L. Cioffi,Esam E. El‐Fakahany	19

About Catherine L. Cioffi

Catherine L. Cioffi is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology, having authored 27 papers that have together received 1.7k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (13 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Neuroscience and Neuropharmacology Research (7 papers). The work is most often cited by research in Hematology (559 citations), Gastroenterology (256 citations) and Genetics (316 citations). Catherine L. Cioffi has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Sayuri Ohno-Jones, Nicholas Lydon, Norman M. Law, Elisabeth Buchdunger, David R. Stover, Brian Druker, Esam E. El‐Fakahany, Brett P. Monia, Michelle Garay and Benjamin R. Bowen. Their work appears in journals such as Biochemical and Biophysical Research Communications, Methods in enzymology on CD-ROM/Methods in enzymology and Journal of Neurochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact